FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056470 [Registered on: 14/08/2023] Trial Registered Prospectively
Last Modified On: 08/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of brahmi Ghrita & ashtang ghrita in Attention Deficit Hyperactive Disorder in children 
Scientific Title of Study   A Comparative Clinical Study On The Effect Of Ashtanga Ghritam & Brahmi Ghritam In Children Suffering From Attention Deficit Hyperactive Disorder. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priyanka Wadhwa 
Designation  PhD Scholar 
Affiliation  Parul University 
Address  Dept of Balroga, Faculty Campus, Parul Institute of Ayurveda, Parul University, Limda, Vadodara
OPD Balroga, Parul Institute of Ayurveda, Parul University, limda, Vadodara
Vadodara
GUJARAT
391760
India 
Phone  8105938269  
Fax    
Email  pwadhwa13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swapnil Raskar 
Designation  Associate professor 
Affiliation  Parul University 
Address  Dept of Balroga, Faculty Campus, Parul Institute of Ayurveda, Parul University
OPD BALROGA, Parul Institute Of Ayurveda, parul University
Vadodara
GUJARAT
391760
India 
Phone  8105938269  
Fax    
Email  neonatecare99@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Priyanka Wadhwa 
Designation  PhD Scholar 
Affiliation  Parul University 
Address  Dept of Balroga, Faculty Campus, Parul Institute of Ayurveda, Parul University, Limda, Vadodara
OPD Balroga, Parul Institute of Ayurveda, Parul University, Limda, Vadodara
Vadodara
GUJARAT
391760
India 
Phone  8105938269  
Fax    
Email  pwadhwa13@gmail.com  
 
Source of Monetary or Material Support  
Parul Institute of Ayurveda, Parul university, limda, vadodara, Gujrat pin:- 391760 
 
Primary Sponsor  
Name  Dr Priyanka Wadhwa 
Address  Patanjali Ayurveda College, Haridwar, Uttrakhand Pin:- 249405 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Swapnil Raskar  Associate professor, Parul Institute of Ayurveda, Parul University, Vadodara, Gujrat 391760 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka wadhwa  Parul Institute Of Ayurveda  OPD Balroga, Parul Institute Of Ayurveda, Limda, Vadodara, Gujrat PIN:_391760
Vadodara
GUJARAT 
8105938269

pwadhwa13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Parul Institute Of Ayurveda, Parul University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F909||Attention-deficit hyperactivity disorder, unspecified type. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Ashtang Ghrita, Reference: Ashtang Hridyam, uttar tantra 1/43-44, Route: Oral, Dosage Form: Ghrita, Dose: 16(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Brahmi Ghrita, Reference: Bhaishjya Ratnavli, Apasmara Chikitsa, Route: Oral, Dosage Form: Ghrita, Dose: 16(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  -Children of either sex
-Children of age group of 6 - 12 years
-Children diagnosed to be suffering from ADHD as per The Diagnostic and Statistical Manual of Mental Disorders (DSM) V criteria
 
 
ExclusionCriteria 
Details  -Mentally retarded children
-Children suffering from any neurological disease
-Children suffering from any severe hepatic / cardiac or renal condition.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Score as per DSM V CRITERIA  day 15
day 30
day 45 
 
Secondary Outcome  
Outcome  TimePoints 
Hyperactivity of Child
Impulsivity of child 
day 15
day 30
day 45 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   21/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
•Attention Deficit Hyperactivity Disorder (ADHD) is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that is frequently displayed and more severe than that typically observed in individuals at a comparable level of development.
•Various studies have reported prevalence of ADHD in Indian Children varying between 3% to 8%. Again being one of the commonest neurobehavioral disorder of childhood, ADHD comprises perhaps 50% of referrals to child neurologists, behavioural therapist and child psychiatrists.
•This disorder is found to be a forerunner of a number of different psychiatric conditions including mood disorders, anxiety disorders and some types of schizophrenia.The symptoms usually become evident in preschool or early years. The median age of onset being 7 years. 
•In view of the adverse effects associated with psycho-stimulants used for the treatment of this disorder, there arises a need of an effective treatment modality.
•Thus this study has been up taken to evaluate the efficacy of Ashtang Ghrita in this condition.
 
Close